| Literature DB >> 34055012 |
Lixin Wang1, Xu Zuo2, Zhuoer Ouyang1, Ping Qiao1, Fang Wang2.
Abstract
BACKGROUND: Aging is an inevitable stage of body development. At the same time, aging is a major cause of cancer, cardiovascular disease, and neurodegenerative diseases. Chinese herbal medicine is a natural substance that can effectively delay aging and is expected to be developed as antiaging drugs in the future. Aim of the review. This paper reviews the antiaging effects of 23 traditional Chinese herbal medicines or their active components. Materials and methods. We reviewed the literature published in the last five years on Chinese herbal medicines or their active ingredients and their antiaging role obtained through the following databases: PubMed, EMBASE, Scopus, and Web of Science.Entities:
Year: 2021 PMID: 34055012 PMCID: PMC8143881 DOI: 10.1155/2021/5591573
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Antiaging research of TCM and its active components with Caenorhabditis elegans as a model.
| Types of TCM | Role form | Component analysis method | Main ingredients | Dose | Life expectancy increased | Key genes | Pathways | References |
|---|---|---|---|---|---|---|---|---|
| Clove | Essential oil | Gas chromatography–mass spectrometry (GC–MS) | Aryophyllene; phenol; 2-methoxyl-3-(2-propenyl) | 1 mg/ml | 15.3% |
| Antioxidant pathway; insulin/IGF-1 signaling pathway (IIS); apoptosis pathway | [ |
| Coix seed | Essential oil | GC–MS | Linoleic acid; oleic acid; palmitic acid | 1mg/ml | 22.79% |
| Antioxidant pathway | [ |
|
| Crude extractions | High performance liquid chromatography (HPLC) | Chlorogenic acid; 1,5-dicaffeoylquinic acid; 1,3-dicaffeoylquinic acid | 500 | 21.87% |
| Antioxidant pathway; IIS | [ |
| Glycyrrhizae radix | Crude extractions | Reverse phase high-performance liquid chromatography (RP-HPLC) | Liquiritin; isoliquiritin; glycyrrhizic acid | 0.24 g/ml | — |
| IIS | [ |
| Gengnianchun | Aqueous extract | — | — | 3.94 mg/ml | 31.3% |
| IIS | [ |
|
| Neutral Polysaccharides | UPLC analysis; FR-IR spectrum | Galactose, glucose, and arabinose | — | — |
| Antioxidant pathway; IIS | [ |
|
| Neutral Polysaccharides | Phenol-sulfuric acid method; HPLC-GPC; FR-IR spectrum; GC-MS | Mannose, glucose, and galactose | 300 | 20.72% |
| IIS | [ |
| Juniper berry ( | Essential oil | GC-MS |
| 10 ppm | 18.5% |
| Antioxidant pathway; IIS | [ |
|
| Natural flavonol; tambulin | — | — | 50 | 16.79% |
| Antioxidant pathway; IIS | [ |
|
| — | — | 1mg/ml | 24% |
| — | [ | |
|
| Aqueous extract | — | — | 1000 | 18.6% |
| IIS | [ |
|
| Aqueous extract | — | — | 7.5 mg/ml | — |
| mTor/s6k pathway; dietary restriction pathway | [ |
|
| Astragaloside IV (AS-IV) | — | — | — | 27.8% |
| Antioxidant pathway; IIS | [ |
Antiaging research of TCM or its active components based on other animal or cell models.
| Types of TCM | Role form | Animal models or cell lines | Induced way | Pathways | Ref. |
|---|---|---|---|---|---|
|
| — | Rat | D-galactose-induced | Glutamine–glutamate metabolic pathway | [ |
|
| Aqueous extract | Silkworm; | — | IIS | [ |
|
| Gentiopicroside (GPS) | Yeast | — | Mitochondrial autophagy pathway; antioxidant pathway | [ |
|
| Aqueous extract, volatile oil (VOZ), petroleum ether (PEZ), and methylene chloride | Mice | D-galactose-induced | PI3K/Akt/Nrf2 signaling pathway | [ |
|
| Fixed oil | Mice | D-galactose-induced | Antioxidant pathway; antiapoptotic pathway | [ |
| Safflower seed | Oil | HaCaT cells and HDF | Ultraviolet B-induced | — | [ |
| Pomegranate | Dried pomegranate juice | Mice | UVB-induced | — | [ |
|
| Hot water extraction | HaCaT | UVB-induced | — | [ |
|
| — | Dermal papilla cells | — | — | [ |
| Ginseng | Ginsenoside Rb1 | Human umbilical vein endothelial cells (HUVEC) | H2O2-induced | SIRT signaling | [ |
Figure 1A flowchart of literature search and selection in this review is described in detail.
Figure 2Chemical structures of some of the main components of TCM.
Figure 3Methodological quality of included in vivo studies.
Figure 4The year of publication of the review article.
Figure 5The country of publication of the review article.